PATENT CLAIM ANALYSIS

Application Number: 15945630
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-10
Patent Classification: ["424", "400000"]

Abstract:
Methods for targeted delivery of therapeutic agents to a target cell or tissue with lipid nanoparticles comprising ApoE3. In embodiments, the invention specifically relates to targeted delivery of anticancer drugs, antibiotics, antifungal drugs, and diagnostic contrast agents, and associated treatment and diagnostic methods. In embodiments, diseases/conditions treated include those associated with over-expression of LDL receptors.

Claim (Index 10):
The method according to  claim 5 , wherein the therapeutic agent is a chemotherapeutic drug and the target cell or tissue is of brain cancer.

Metadata:
- Claim Count in Document: 48.0
- Percentile: 91.0
- Lexical Diversity: 1.48837
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11648808', '10724833', '11802727', '11802197', '11802198']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7858687263092956
- 35 USC 102 Novelty (BERT): 0.5346039070275865
- Combined Prediction Score: 0.7607422443811247
- Mean Citation Score: 356.06647200000015
- Max Citation Score: 371.93008
- Similarity Product: 281.9207897938728

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test